UPDATE: Raymond James Downgrades Arcturus Therapeutics (ARCT) to Market Perform on Vaccine Candidate Results
Tweet Send to a Friend
(Updated - December 29, 2020 8:00 AM EST)
Raymond James analyst Steven Seedhouse downgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Steven Seedhouse downgraded Arcturus Therapeutics (NASDAQ: ARCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
